Latest News

• Methotrexate Can Be Stopped in Certolizumab Combo for RA Patients with RA who achieve LDA with certolizumab plus methotrexate had similar rates of worsening symptoms following either stopping or continuing methotrexate.
  Medscape Medical News, April 11, 2025
• No Increased Birth Defect Risk From Smoking Cessation Meds No increase in risk for major congenital malformations is observed in infants born to mothers receiving smoking cessation therapies, according to a large cohort study.
  Medscape Medical News, April 11, 2025
• AAD 2025 As Dermatology Continues to Grow, Pediatric Derm Numbers Lag Pediatric dermatologists love what they do but struggle to attract others to their subspecialty.
  Medscape Medical News, April 11, 2025
• 4 Things to Know About New Medicare Advantage Rules Prior authorization leeway will be trimmed while health plans get more money under new federal rules for Medicare Advantage plans.
  Medscape Medical News, April 11, 2025
• Researchers Link Metabolic Age Clock and COPD The same biological processes that drive aging — such as energy loss — may also contribute to lung diseases like chronic obstructive pulmonary disease.
  Medscape Medical News, April 11, 2025
• ACP-IM 2025 Eye-Opening Updates in Insomnia and OSA Expert shares treatment approaches for insomnia and alternatives for patients With PAP-intolerance.
  Medscape Medical News, April 11, 2025
• Online Program Helps Women Improve Sexual Dysfunction Both mindfulness-based therapy and cognitive-behavioral therapy appear to be effective, allowing users to decide which approach may work better for them.
  Medscape Medical News, April 11, 2025
• Popular Joint Supplement Cuts Nephropathy Risk in T2D People with type 2 diabetes who regularly use the supplement glucosamine have a lower risk for microvascular complications and diabetic nephropathy, a prospective observational study finds.
  Medscape Medical News, April 11, 2025
• AAN 2025 Prenatal Folic Acid May Boost Brain Health in Offspring Taking folic acid early in pregnancy is safe, even at high doses, and associated with improved neuropsychological outcomes in the offspring at age 6 years.
  Medscape Medical News, April 11, 2025
• Canadian Pediatricians Ill Prepared to Treat Drug Overdoses Illicit drug toxicity is an ‘escalating public health emergency’ in Canada that affects adolescents as well as adults.
  Medscape Medical News, April 11, 2025
• Australian Woman Gives Birth to Wrong Couple's Baby An Australian woman has given birth to a stranger's baby after a fertility doctor accidentally implanted the wrong embryo, the clinic owner said in its apology letter while...
  Reuters Health Information, April 10, 2025
• Alert FDA Clears Dexcom G7 CGM for 15-Day Wear The US Food and Drug Administration has cleared the latest version to last 5 days longer than previously for adult users.
  Medscape Medical News, April 10, 2025
• Exclusive-US NIH Reverses Conference Travel Ban for Scientists The U.S. National Institutes of Health has reversed a ban on scientists traveling for conferences and meetings, a Department of Health and Human Services spokesperson told...
  Reuters Health Information, April 10, 2025
• Sucralose Affects Brain Mechanisms That Regulate Appetite The noncaloric sweetener sucralose appears to influence how the hypothalamus interprets sweet taste and metabolic signals, potentially influencing appetite regulation over time.
  Medscape Medical News, April 10, 2025
• Novel Blood Thinner Shows Promise in Atrial Fibrillation A recent study reveals that asundexian may reduce the risk for stroke and bleeding in patients with atrial fibrillation and limited prior anticoagulant exposure.
  Medscape Medical News, April 10, 2025
• Lacerations Most Common Ear Injuries in US Over 20 Years A study analyzes two decades of data on traumatic ear injuries, highlighting key demographics and injury patterns across age groups.
  Medscape Medical News, April 10, 2025
• Can Shorter Antibiotic Treatment Benefit Kids With UTIs? Individualised antibiotic treatment increases the risk for recurrence but reduces antibiotic use and the number of adverse event days in children with febrile UTIs, a Danish trial reveals.
  Medscape News UK, April 10, 2025
• Inflammatory Marker Predicts Liver Cancer Risk in T2D An inflammatory biomarker, YKL-40, serves as a reliable prognostic marker for liver and bladder cancers in patients with newly diagnosed T2D, outperforming CRP for these cancers.
  Medscape News UK, April 10, 2025
• Novel JAK Inhibitor Improves QOL in Chronic Hand Eczema Treatment with delgocitinib cream leads to improvement in health-related quality of life in patients with moderate to severe chronic hand eczema, according to a phase 2b trial.
  Medscape News UK, April 10, 2025
• DLBCL: Novel Drug Combo Boosts Survival in Older Adults Innovative polatuzumab vedotin plus R-CHP therapy reshapes treatment of older adult patients with diffuse large B-cell lymphoma.
  Medscape Medical News, April 10, 2025